Sera Prognostics (SERA) Assets Average (2021 - 2026)
Sera Prognostics (SERA) posted Assets Average of $97.7 million for Q1 2026, down 6.94% on a QoQ basis from $105.0 million in Q4 2025, and up 2.47% year-over-year from $95.4 million in Q1 2025.
Sera Prognostics (SERA) Assets Average (2021 - 2026) Analysis & Trends
Sera Prognostics' Assets Average history runs 6 years deep, the most recent figure standing at $97.7 million for Q1 2026.
- Quarterly Assets Average rose 2.47% year-over-year to $97.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97.7 million (up 2.47% YoY) and the FY2025 annual result came in at $87.3 million, up 3.86% from the prior year.
- Assets Average was $97.7 million for Q1 2026 at Sera Prognostics, down from $105.0 million in the prior quarter.
- Across five years, Assets Average topped out at $140.9 million in Q1 2022 and bottomed at $75.8 million in Q4 2024.
- A 5-year average of $104.0 million and a median of $101.1 million in 2023 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average fell 22.71% — and 2025, when it surged 38.58%.
- Sera Prognostics' Assets Average stood at $116.4 million in 2022, then fell by 20.35% to $92.7 million in 2023, then fell by 18.29% to $75.8 million in 2024, then surged by 38.58% to $105.0 million in 2025, then fell by 6.94% to $97.7 million in 2026.
- Business Quant data shows SERA's Assets Average at $97.7 million in Q1 2026, $105.0 million in Q4 2025, and $110.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.49 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.64 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.57 Bn |
| 10 | Sera Prognostics | 109.06 Mn | 109.06 Mn | -28,000.00 | 97.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.74 Mn |
| Dec 31, 2025 | 105.03 Mn |
| Sep 30, 2025 | 109.98 Mn |
| Jun 30, 2025 | 115.01 Mn |
| Mar 31, 2025 | 95.38 Mn |
| Dec 31, 2024 | 75.79 Mn |
| Sep 30, 2024 | 81.93 Mn |
| Jun 30, 2024 | 87.37 Mn |
| Mar 31, 2024 | 92.66 Mn |
| Dec 31, 2023 | 92.75 Mn |
| Sep 30, 2023 | 93.37 Mn |
| Jun 30, 2023 | 101.15 Mn |
| Mar 31, 2023 | 110.97 Mn |
| Dec 31, 2022 | 116.45 Mn |
| Sep 30, 2022 | 120.81 Mn |
| Jun 30, 2022 | 129.96 Mn |
| Mar 31, 2022 | 140.95 Mn |
| Dec 31, 2021 | 150.36 Mn |
| Sep 30, 2021 | 124.38 Mn |